Dan Beck

708 total citations
22 papers, 541 citations indexed

About

Dan Beck is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Dan Beck has authored 22 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Reproductive Medicine, 6 papers in Obstetrics and Gynecology and 5 papers in Surgery. Recurrent topics in Dan Beck's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (5 papers) and BRCA gene mutations in cancer (2 papers). Dan Beck is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (5 papers) and BRCA gene mutations in cancer (2 papers). Dan Beck collaborates with scholars based in Israel, United States and Australia. Dan Beck's co-authors include Joseph M. Brandes, Shraga Rottem, Israel Thaler, Z. Weiner, Melanie Deutsch, Ruth Gershoni‐Baruch, Hedviga Kerner, Joan Gil, Liane Deligdisch and Hai Shan Wu and has published in prestigious journals such as Cancer, American Journal of Obstetrics and Gynecology and European Journal of Cancer.

In The Last Decade

Dan Beck

22 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Beck Israel 13 327 208 115 99 68 22 541
Zbigniew Kojs Poland 12 129 0.4× 125 0.6× 66 0.6× 39 0.4× 85 1.3× 70 453
Huijuan Ge China 13 116 0.4× 79 0.4× 51 0.4× 72 0.7× 50 0.7× 32 709
Zoltán Hernádi Hungary 13 168 0.5× 94 0.5× 125 1.1× 12 0.1× 129 1.9× 40 508
Alberto Villanueva Spain 8 131 0.4× 46 0.2× 67 0.6× 50 0.5× 163 2.4× 12 419
Ola A. Harb Egypt 12 128 0.4× 108 0.5× 135 1.2× 14 0.1× 59 0.9× 61 462
Chiung‐Ru Lai Taiwan 14 115 0.4× 103 0.5× 116 1.0× 10 0.1× 151 2.2× 24 504
Satoru Munakata Japan 12 70 0.2× 76 0.4× 105 0.9× 19 0.2× 103 1.5× 47 458
Juan Zhao China 12 70 0.2× 41 0.2× 36 0.3× 70 0.7× 81 1.2× 34 477
Erin Bishop United States 11 123 0.4× 182 0.9× 85 0.7× 11 0.1× 115 1.7× 40 443
Erik Škof Slovenia 11 115 0.4× 30 0.1× 75 0.7× 49 0.5× 173 2.5× 34 347

Countries citing papers authored by Dan Beck

Since Specialization
Citations

This map shows the geographic impact of Dan Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Beck more than expected).

Fields of papers citing papers by Dan Beck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Beck. The network helps show where Dan Beck may publish in the future.

Co-authorship network of co-authors of Dan Beck

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Beck. A scholar is included among the top collaborators of Dan Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Beck. Dan Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bar‐Sela, Gil, et al.. (2006). Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract.. PubMed. 26(1B). 709–13. 19 indexed citations
2.
Kerner, Ram, Edmond Sabo, Ruth Gershoni‐Baruch, Dan Beck, & Ofer Ben‐Izhak. (2005). Expression of cell cycle regulatory proteins in ovaries prophylactically removed from Jewish Ashkenazi BRCA1 and BRCA2 mutation carriers: Correlation with histopathology. Gynecologic Oncology. 99(2). 367–375. 13 indexed citations
3.
Beck, Dan, et al.. (2005). The role of hybrid PET/CT in the evaluation of patients with cervical cancer. Gynecologic Oncology. 100(1). 65–69. 46 indexed citations
4.
Postovsky, Sergey, et al.. (2004). GROWING TERATOMA SYNDROME TREATED BY INTERFERON ALPHA-2β: Case Report and Literature Review. Pediatric Hematology and Oncology. 21(1). 9–16. 3 indexed citations
5.
Fishman, Ami, Angela Chetrit, Liat Lerner‐Geva, et al.. (2000). Patients with Double Primary Tumors in the Breast and Ovary— Clinical Characteristics and BRCA1–2 Mutations Status. Gynecologic Oncology. 79(1). 74–78. 17 indexed citations
6.
Allison, James P., Helen E. Thomas, Dan Beck, et al.. (2000). Transgenic overexpression of human Bcl-2 in islet β cells inhibits apoptosis but does not prevent autoimmune destruction. International Immunology. 12(1). 9–17. 52 indexed citations
7.
Agrawal, Amit, Z. Weiner, H. Kerner, et al.. (2000). The Diagnostic Value of Power Doppler Measurements in the Endometrium of Women with Postmenopausal Bleeding. Gynecologic Oncology. 77(2). 243–247. 21 indexed citations
8.
Deligdisch, Liane, Joan Gil, Hedviga Kerner, et al.. (1999). Ovarian dysplasia in prophylactic oophorectomy specimens. Cancer. 86(8). 1544–1550. 2 indexed citations
9.
Deligdisch, Liane, Joan Gil, Hedviga Kerner, et al.. (1999). Ovarian dysplasia in prophylactic oophorectomy specimens. Cancer. 86(8). 1544–1550. 83 indexed citations
10.
Hanekop, G., et al.. (1998). [Pain therapy in tumor patients and in palliative medicine. 2: Invasive measures].. PubMed. 123(6). 664–77. 3 indexed citations
11.
Kerner, H., et al.. (1995). An immunohistochemical study of estrogen and progesterone receptors in adenocarcinoma of the endometrium and in the adjacent mucosa. International Journal of Gynecological Cancer. 5(4). 275–281. 7 indexed citations
12.
Weiner, Zeev, Dan Beck, Shraga Rottem, Joseph M. Brandes, & Israel Thaler. (1993). Uterine artery flow velocity waveforms and color flow imaging in women with perimenopausal and postmenopausal bleeding. Acta Obstetricia Et Gynecologica Scandinavica. 72(3). 162–166. 34 indexed citations
13.
Weiner, Z., et al.. (1993). Screening for ovarian cancer in women with breast cancer with transvaginal sonography and color flow imaging. Journal of Ultrasound in Medicine. 12(7). 387–393. 21 indexed citations
14.
Beck, Dan, et al.. (1993). Long term survival of patients with epithelial ovarian carcinoma treated with multimodal therapy. European Journal of Cancer. 29. S134–S134. 1 indexed citations
15.
Weiner, Z., Israel Thaler, Dan Beck, et al.. (1992). Differentiating Malignant From Benign Ovarian Tumors With Transvaginal Color Flow Imaging. Journal of diagnostic medical sonography. 8(3). 164–164. 119 indexed citations
16.
Deutsch, Michael, et al.. (1986). Successful Surgical Management of a Severe Case of Starch Peritonitis. Gynecologic and Obstetric Investigation. 22(2). 110–112. 1 indexed citations
17.
Stein, Moshe, Mariana Steiner, Baruch Klein, et al.. (1986). Involvement of the central nervous system by ovarian carcinoma. Cancer. 58(9). 2066–2069. 51 indexed citations
18.
Blumenfeld, Zeev, Hedviga Kerner, Israel Thaler, Michael Deutsch, & Dan Beck. (1984). Increased Alpha-Fetoprotein Levels in Mixed Mesodermal Tumor of the Ovary. Gynecologic and Obstetric Investigation. 17(4). 169–173. 4 indexed citations
19.
Schelper, Robert L., et al.. (1984). 13 PROTEINS OF HYALINE INCLUSIONS IN MENINGOMA. Journal of Neuropathology & Experimental Neurology. 43(3). 297–297. 6 indexed citations
20.
Beck, Dan, Haim Ginsburg, & Yehudith Naot. (1977). The modulating effect of human chorionic gonadotropin on lymphocyte blastogenesis. American Journal of Obstetrics and Gynecology. 129(1). 14–20. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026